These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14747845)

  • 1. Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma.
    Williams JA
    Drug News Perspect; 2003 Dec; 16(10):657-62. PubMed ID: 14747845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.
    Williams JA; Guicherit OM; Zaharian BI; Xu Y; Chai L; Wichterle H; Kon C; Gatchalian C; Porter JA; Rubin LL; Wang FY
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4616-21. PubMed ID: 12679522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
    Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
    Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
    Danhof R; Lewis K; Brown M
    Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma.
    Jain R; Dubey SK; Singhvi G
    Drug Discov Today; 2022 Apr; 27(4):1176-1183. PubMed ID: 34896624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Hedgehog pathway inhibitors in Basal cell carcinoma.
    Basset-Seguin N; Sharpe HJ; de Sauvage FJ
    Mol Cancer Ther; 2015 Mar; 14(3):633-41. PubMed ID: 25585509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
    Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
    Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors.
    Dessinioti C; Plaka M; Soura E; Mortaki D; Papaxoinis G; Gogas H; Stratigos AJ
    Oncologist; 2019 Aug; 24(8):e755-e764. PubMed ID: 31073024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
    Dheeraj A; Rigby CM; O'Bryant CL; Agarwal C; Singh RP; Deep G; Agarwal R
    Photochem Photobiol; 2017 Jul; 93(4):999-1007. PubMed ID: 28120452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.
    Eberl M; Mangelberger D; Swanson JB; Verhaegen ME; Harms PW; Frohm ML; Dlugosz AA; Wong SY
    Cancer Cell; 2018 Feb; 33(2):229-243.e4. PubMed ID: 29395868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vismodegib in basal cell carcinoma.
    Amaria RN; Bowles DW; Lewis KD; Jimeno A
    Drugs Today (Barc); 2012 Jul; 48(7):459-67. PubMed ID: 22844657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
    Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
    Hafner C
    Hautarzt; 2010 Apr; 61(4):356-8. PubMed ID: 20309511
    [No Abstract]   [Full Text] [Related]  

  • 18. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
    Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
    Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog Pathway Inhibition.
    Sekulic A; Von Hoff D
    Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
    Ruiz Salas V; Alegre M; Garcés JR; Puig L
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.